LSL Pharma Group Inc. (TSXV:LSL)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Contract Manufacturing	10.54M	Log In
Eye-Care	7.21M	Log In
Liquid and Semi-solid Pharmaceutical, Natural Health Products, Cosmetic Products, Sterile Ophthalmic Pharmaceuticals	-	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Canada	17.75M	Log In
Canada Growth	76.98%	Log In